The Law of Chemical, Metallurgical and Pharmaceutical PatentsHoward I. Forman Central Book Company, 1967 - 863 lappuses |
No grāmatas satura
1.–3. rezultāts no 73.
130. lappuse
... limited to being a benefit to the applicant from a foreign country should he be in- volved in an interference , and that Section 119 was intended to be limited to this single favorable aspect in favor of the foreign appli- cant . For ...
... limited to being a benefit to the applicant from a foreign country should he be in- volved in an interference , and that Section 119 was intended to be limited to this single favorable aspect in favor of the foreign appli- cant . For ...
198. lappuse
... limited to combination rejections . You can file lots of affidavits on obviousness to approach it in other ways as well . But my interpre- tation of Palmquist is limited to combinations where you can elimi- nate one as of the time the ...
... limited to combination rejections . You can file lots of affidavits on obviousness to approach it in other ways as well . But my interpre- tation of Palmquist is limited to combinations where you can elimi- nate one as of the time the ...
542. lappuse
... limited to the manufacture and sale of a designated pharmaceutical grade of those resins . A less frequent prohibition , but one that could be very important to the licensor in certain situations , is a covenant restricting operation by ...
... limited to the manufacture and sale of a designated pharmaceutical grade of those resins . A less frequent prohibition , but one that could be very important to the licensor in certain situations , is a covenant restricting operation by ...
Saturs
Chapter | 1 |
By CHARLES C PRICE | 15 |
By JOHN T CONNOR AND I LOUIS WOLK | 25 |
Autortiesības | |
15 citas sadaļas nav parādītas.
Bieži izmantoti vārdi un frāzes
2nd Cir affidavit alloy assignment basis Board of Appeals chemical compound chemical patent chromium claims Company considered Corp court held Court of Customs Customs and Patent decision diligence disclosed discovery discussed doctrine of equivalents double patenting drug effect estoppel Examiner example fact filing date granted industry infringement ingredients interference interference proceedings invalid inventor inventorship involved issue license licensor limited machine manufacture Markush material ment method motion obtain obvious party Patent Act Patent Appeals patent application Patent Attorney Patent Examining patent law Patent Office patent system patented invention pharmaceutical present printed publication prior art priority problem proof properties question reason reduction to practice reference reissue rejection result royalty Rule Section 103 situation skilled SOC'Y specification statement statute statutory steel subject matter supra thing tion U.S. Patent United unobvious vention